Vulcan Materials (VMC) Form 144: 4,853 shares, $1.43M sale
Vulcan Materials (VMC) filed a Form 144 indicating a planned sale of 4,853 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,434,714.50.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vulcan Materials (VMC) filed a Form 144 indicating a planned sale of 4,853 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,434,714.50. The filing lists an approximate sale date of 11/12/2025 on the NYSE.
The seller acquired these shares on 11/11/2025 via an exercise of shares for cash, matching the 4,853 shares to be sold. In the prior three months, the same seller reported sales of 4,243 shares on 11/10/2025 for $1,229,451.68 and 5,819 shares on 11/04/2025 for $1,700,660.94. Shares outstanding were 132,130,905; this is a baseline figure, not the amount being sold.
Insights
Administrative Rule 144 notice of intended insider sale; neutral.
This Form 144 lists a proposed sale of 4,853 VMC common shares with an aggregate market value of $1,434,714.50, to be executed via Morgan Stanley on the NYSE. The shares were obtained on 11/11/2025 through an exercise paid in cash, aligning with Rule 144 disclosure norms.
Form 144 is a notice and does not guarantee execution or pricing; actual sales depend on market conditions and the seller’s decisions. The filing also discloses prior sales in the last three months: 4,243 shares for $1,229,451.68 on 11/10/2025 and 5,819 shares for $1,700,660.94 on 11/04/2025.
Investor impact typically depends on size relative to float. The document lists 132,130,905 shares outstanding; the notice itself is informational and neutral in tone.
AI-generated analysis. How Rhea-AI works. Not financial advice.